Dorothy S Lane

Author PubWeight™ 106.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006 8.73
2 Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010 7.12
3 Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006 6.51
4 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004 5.35
5 Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009 4.80
6 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003 4.03
7 Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol 2009 3.33
8 Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006 3.29
9 Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol 2010 3.17
10 Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol 2008 3.05
11 Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006 2.97
12 Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol 2008 2.79
13 Frequency and predictive value of a mammographic recommendation for short-interval follow-up. J Natl Cancer Inst 2003 2.64
14 Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. J Natl Cancer Inst 2013 2.45
15 Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007 2.37
16 Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst 2007 2.36
17 Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005 2.32
18 Calcium and vitamin D supplementation and cognitive impairment in the women's health initiative. J Am Geriatr Soc 2012 2.30
19 Sex hormone levels and risk of breast cancer with estrogen plus progestin. J Natl Cancer Inst 2013 1.60
20 Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative. Menopause 2011 1.59
21 Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol 2011 1.57
22 Clinical breast examination: practical recommendations for optimizing performance and reporting. CA Cancer J Clin 2004 1.52
23 Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006 1.31
24 Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012 1.26
25 Nutrition and physical activity cancer prevention guidelines, cancer risk, and mortality in the women's health initiative. Cancer Prev Res (Phila) 2014 1.26
26 The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study. J Gerontol A Biol Sci Med Sci 2009 1.21
27 Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers. J Natl Cancer Inst 2011 1.17
28 Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev 2009 1.11
29 Colorectal cancer screening attitudes and practices preferences for decision making. Am J Prev Med 2005 1.10
30 Effectiveness of telephone counseling for mammography: results from five randomized trials. Prev Med 2002 1.08
31 Relationship of social support and social burden to repeated breast cancer screening in the women's health initiative. Health Psychol 2004 1.08
32 Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative. Int J Cancer 2014 1.03
33 The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med 2010 1.02
34 Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev 2013 1.00
35 Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Res 2014 0.95
36 A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Res Treat 2008 0.95
37 Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program. Cancer 2013 0.92
38 Clinical case management and navigation for colonoscopy screening in an academic medical center. Cancer 2013 0.90
39 Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative. Nutr Cancer 2011 0.88
40 Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health (Larchmt) 2010 0.88
41 Toward a positive aging phenotype for older women: observations from the women's health initiative. J Gerontol A Biol Sci Med Sci 2012 0.87
42 Perceptions of risk factors for breast cancer and attitudes toward mammography among women who are current, ex- and non-smokers. Women Health 2002 0.87
43 The association between NSAID use and colorectal cancer mortality: results from the women's health initiative. Cancer Epidemiol Biomarkers Prev 2012 0.86
44 Effectiveness of women's telephone counseling and physician education to improve mammography screening among women who underuse mammography. Ann Behav Med 2002 0.86
45 Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 2007 0.86
46 Incidence of cervical cytological abnormalities with aging in the women's health initiative: a randomized controlled trial. Obstet Gynecol 2006 0.85
47 Oral bisphosphonate use and colorectal cancer incidence in the Women's Health Initiative. J Bone Miner Res 2013 0.84
48 Low-fat dietary pattern and risk of benign proliferative breast disease: a randomized, controlled dietary modification trial. Cancer Prev Res (Phila) 2008 0.83
49 Colorectal cancer screening among users of county health centers and users of private physician practices. Public Health Rep 2009 0.81
50 Body mass index and screening for colorectal cancer: gender and attitudinal factors. Cancer Epidemiol 2012 0.79
51 Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study. Breast Cancer Res Treat 2008 0.79
52 Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program. Cancer 2013 0.78
53 Mammography interval and breast cancer mortality in women over the age of 75. Breast Cancer Res Treat 2014 0.77
54 Changes in the inflammatory potential of diet over time and risk of colorectal cancer in postmenopausal women. Am J Epidemiol 2017 0.75
55 Perceptions of risk factors for colorectal cancer and colorectal cancer risk-related behaviors among current, ex-, and nonsmokers. J Cancer Educ 2013 0.75
56 Re: Short-interval follow-up mammography: are we doing the right thing? J Natl Cancer Inst 2003 0.75
57 Response to Annweiler and Beauchet. J Am Geriatr Soc 2013 0.75
58 Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women. Menopause 2016 0.75
59 Walking speed, physical activity, and breast cancer in postmenopausal women. Eur J Cancer Prev 2014 0.75
60 Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women. Eur J Cancer Prev 2016 0.75
61 Guidance at the many edges of evidence: position statements of the American College of Preventive Medicine. Am J Prev Med 2002 0.75
62 Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause 2017 0.75